COMMUNITY DEVELOPMENT DEPARTMENT
BUILDING & SAFETY AND PLANNING DIVISIONS
The City of Burbank is committed to caring for the health and well-being of our employees, customers and community – and to reducing the threat of COVID-19.
Effective Thursday, April 2, 2020, the City’s Community Development Department will transition to modified operations that establish online services. Public counter hours at the Community Services Building are closed until further notice.
All residents and customers will be required to utilize online services as the primary means for Building & Safety and Planning Division Services, including but not limited to permit application review filing/intake, payment of fees, consultation, permit issuance, clearance, and inspection services.
To the extent possible, the Community Development Department’s Building & Safety and Planning Divisions will continue to operate and provide services to ensure the continued processing of permit applications. Additional details on each Division’s operation can be found below:
BUILDING & SAFETY DIVISION ONLINE SERVICES
Identified below are the Building & Safety Division Services that will be provided online – follow each link for additional information. For more information, and/or other questions, customers can contact the Building & Safety Division via email at firstname.lastname@example.org or via phone at 818-238-5220.
PLANNING DIVISION ONLINE SERVICES
Identified below are the Planning Division Services that will be provided online. For more information, customers can contact the Planning Division via email at email@example.com.
Again, effective Thursday, April 2, 2020, the City’s Community Development Department will transition to the modified operations outlined above, that allow for online services. We recognize this is a challenging time for all, and we remain deeply committed to the health and well-being of our employees, customers and community. We will continue to monitor developments, adjust where necessary, and do our part to reduce the spread of COVID-19.